Biomark Capital Management Co. LLC 13F Holdings · last filed Q3 2018
Biomark Capital Management Co. LLC reported 2 securities worth $8.90M in its SEC 13F filing for Q3 2018 (period ended 2018-09-30). Top holdings: ADMA (99.96%), MBVXQ (0.04%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ADMA | ADMA BIOLOGICS, INC. | $8.9M | 99.96% | 1.4M | Hold |
| 2 | MBVXQ | MABVAX THERAPEUTICS HOLDINGS, INC. | $4,000 | 0.04% | 8,903 | Hold |
Source: SEC Form 13F filings · as of 2018-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR